Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Diseases of the Thyroid

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    September 2022
  1. MILAS ZL, Neelands B, Trufan SJ, Benbow J, et al
    Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment.
    Anticancer Res. 2022;42:4429-4437.
    PubMed     Abstract available


    May 2022
  2. KUNTE S, Sharett J, Wei W, Nasr C, et al
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes.
    Anticancer Res. 2022;42:2531-2539.
    PubMed     Abstract available


  3. ACHILLA C, Papavramidis T, Angelis L, Chatzikyriakidou A, et al
    The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer.
    Anticancer Res. 2022;42:2261-2276.
    PubMed     Abstract available


  4. KLIMAITE R, Kazokaite M, Kondrotiene A, Dauksiene D, et al
    Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer.
    Anticancer Res. 2022;42:2289-2299.
    PubMed     Abstract available


  5. HUANG TS, Lee JJ, Huang SY, Cheng SP, et al
    Regulation of Expression of Sterol Regulatory Element-binding Protein 1 in Thyroid Cancer Cells.
    Anticancer Res. 2022;42:2487-2493.
    PubMed     Abstract available


    March 2022
  6. LIU A, Borges PM, Tay YS, Thompson LDR, et al
    Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of PTEN Hamartoma Tumor Syndrome in an Adult Patient With a Novel RECQL4 Mutation.
    Anticancer Res. 2022;42:1481-1485.
    PubMed     Abstract available


  7. JIN MC, Qian ZJ, Megwalu UC
    Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
    Anticancer Res. 2022;42:1359-1365.
    PubMed     Abstract available


    January 2022
  8. MEIROVITZ A, Nisman B, Allweis TM, Carmon E, et al
    Thyroid Hormones and Morphological Features of Primary Breast Cancer.
    Anticancer Res. 2022;42:253-261.
    PubMed     Abstract available


    November 2021
  9. NA YM, Cho JS, Park MH
    Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Anticancer Res. 2021;41:5713-5721.
    PubMed     Abstract available


    July 2021
  10. CAO C, Poti SM, Ledgerwood LG, Lai J, et al
    Mixed HPV-related Neuroendocrine Carcinoma and HPV-related Squamous Cell Carcinoma of the Base of Tongue in a Patient With Incidental Identification of Synchronous Metastatic Papillary Thyroid Carcinoma.
    Anticancer Res. 2021;41:3639-3642.
    PubMed     Abstract available


    March 2021
  11. FUKUDA N, Toda K, Ohmoto A, Wang X, et al
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Anticancer Res. 2021;41:1683-1691.
    PubMed     Abstract available


  12. MARCHAND-CRETY C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, et al
    Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
    Anticancer Res. 2021;41:1555-1561.
    PubMed     Abstract available


    December 2020
  13. LORNTZSEN B, Jacobsen AB, GrOholt KK, Sigstad E, et al
    Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment.
    Anticancer Res. 2020;40:6979-6985.
    PubMed     Abstract available


    November 2020
  14. KIM SH, Cho YK, Huh JH, Kang JG, et al
    Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.
    Anticancer Res. 2020;40:6137-6150.
    PubMed     Abstract available


  15. NISMAN B, Allweis TM, Carmon E, Kadouri L, et al
    Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
    Anticancer Res. 2020;40:6417-6428.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: